1Saw S M,Shih-yen E C,Koh A,et al,Interventions to retard myopia progression in children:an evidence-based update[J].Ophthalmology,2002,109(2):415-421.
1Shih YF,Hsiao CK,Chen CJ,et al.An intervention trial on efficacy of atropine and multi-focal glasses in controlling myopic progression[J].Acta Ophthalmol Scand,2001,79(3):233-236.
2Saw SM,Shih-Yen EC,Koh A,et al.Interventions to retard myopia progression in children:an evidence-based update[J].Ophthalmology,2002,109(2):415-421.
3Hu DN.Long-term treatment of myopia with atropine[A].In:Tokoro T,editor.Myopia Updates[M].Tokyo:Springer,1998.205-209.
4Shih YF,Chen CH,Chou AC,et al.Effects of different concentrations of atropine on controlling myopia in myopic children[J].J Ocul Pharmacol Ther,1999,15(1):85-90.
5Tigges M,Iuvone PM,Fernandes A,et al.Effects of muscarinic cholinergic receptor antagonists on postnatal eye growth of rhesus monkeys[J].Optom Vis Sci,1999,76(6):397-407.
6Cottriall CL,McBrien NA.The M1 muscarinic antagonist pirenzepine reduces myopia and eye enlargement in the tree shrew[J].Invest Ophthalmol Vis Sci,1996,37(7):1368-1379.
7Karageozian H.Pirenzepine(PIR) Ophthalmic Gel:Concentration-and time-response in rabbits[J].Invest Ophthalmol Vis Sci,2001,42(Suppl):59.
8Siatkowski R.Pirenzepine 2% Opthalmic Gel retards myopic progression in 8～12 year old children[J].Invest Ophthalmol Vis Sci,2003,44(ARVO E-Abstract):4778.
9Siatkowski R.Pirenzepine 2% Ophthalmic Gel retards myopic progression in 8～12 old children over two years[J].Invest Ophthalmol Vis Sci,2004,45(ARVO E-Abstract):2733.
10Luft WA,Ming Y,Stell WK.Variable effects of previously untested muscarinic receptor antagonists on experimental myopia[J].Invest Ophthalmol Vis Sci,2003,44(3):1330-1338.
